❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ News archive

Digital Public Defence Apr. 26, 2021 12:15 Maxi-Lu Böschen

Maxi-Lu Böschen
Maxi-Lu Böschen

MSc Maxi-Lu Böschen from the Experimental Immunotherapy Group headed by Johanna Olweus will be defending her thesis Towards new T cell receptor-based cancer immunotherapy for the degree of PhD (Philosophiae Doctor).

Time and place: Apr. 26, 2021 12:15 PM, Zoom
 

Links:

Read complete announcement from UiO home page

Maxi-Lu Böschen

The Experimental Immunotherapy Group, headed by Johanna Olweus

 
Scroll to top

Home Cancer Medicine Institute for Cancer Research

  • Dept. of Cancer Genetics
  • Dept. of Cancer Immunology
  • Dept. of Molecular Cell Biology
  • Dept. of Molecular Oncology
  • Dept. of Radiation Biology
  • Dept. of Tumor Biology
  • Dept. of Core Facilities
  • Institute employees
  • Dept./group overview
  • Publications
  • Institute administration
  • Annual reports
  • Institute seminars
  • Vacant positions
  • News archive
  • Scientific Advisory Board
  • ehåndbok/HES procedures

Recent publications

From major journals, first or last author from the Institute for Cancer Research

Nymoen HM, Zhao Z, Horndalsveen H, Bjaanæs MM, Grønberg BH, Halvorsen T, Madebo T, Aanerud M, Koivunen J, Oselin K, Cicenas S, Helbekkmo N, Ahvonen J, Silvoniemi M, Alver TN, Dalen T, Öjlert ÅK, Farooqi SJ, Helland Å, Haakensen VD (2026)
Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy
Mol Oncol (in press)
DOI 10.1002/1878-0261.70326, PubMed 42703809

Totland MZ, Rasmussen NL, Elster VCW, Arnesen KI, Bergmann DG, Bergill I, Stenersen JM, Larsen M, Moe JJ, Basing S, Sørensen V, Aasen T, Leithe E (2026)
Regulation of ubiquitination and degradation of the gap junction channel protein Connexin43 involves the concerted action of multiple members of the NEDD4 family of E3 ubiquitin ligases
Cancer Lett, 659, 218796 (in press)
DOI 10.1016/j.canlet.2026.218796, PubMed 42641867

Haukaas HS, Carlsson SR, Lystad AH (2026)
Dealing with membrane stress through CASM
Autophagy, 1-10 (in press)
DOI 10.1080/15548627.2026.2717033, PubMed 42627010

More selected publications

Most recent publications

Nymoen HM, Zhao Z, Horndalsveen H, Bjaanæs MM, Grønberg BH, Halvorsen T, Madebo T, Aanerud M, Koivunen J, Oselin K, Cicenas S, Helbekkmo N, Ahvonen J, Silvoniemi M, Alver TN, Dalen T, Öjlert ÅK, Farooqi SJ, Helland Å, Haakensen VD (2026)
Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy
Mol Oncol (in press)
DOI 10.1002/1878-0261.70326, PubMed 42703809

Kjæstad E, Thiis-Evensen E, Sveen A, Bakka AO, Schultz JK (2026)
Small Bowel Cancer: Implications of Preoperative Work-Up on Surgical Strategy
World J Surg (in press)
DOI 10.1002/wjs.70547, PubMed 42693594

Robsahm TE, Skog A, Veierød MB, Roscher I, Brevig T, Ghiasvand R, Møller B (2026)
Nationwide study of cutaneous basal cell carcinoma incidence trends in Norway, 2012-2022
Cancer Epidemiol, 105, 103210 (in press)
DOI 10.1016/j.canep.2026.103210, PubMed 42673903

More publications

Annual summary of publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)